🚀 VC round data is live in beta, check it out!
Nextgen Biomed Valuation Multiples
Discover revenue and EBITDA valuation multiples for Nextgen Biomed and similar public comparables like Biosenic, Aptahem, HCW Biologics, China SXT Pharmaceuticals and more.
Nextgen Biomed Overview
About Nextgen Biomed
NextGen Biomed Ltd is pharmaceutical company. It manufactures medical instruments. Its products include pain-free auto-injectors, lancet devices and personal use pain alleviators. It develops and markets medical equipments. Its product line include DPS-101, which is used for treatment for psoriasis. Its other product line include DPS-101 phase II/III is in clinical trial.
Founded
1990
HQ
Employees
N/A
Website
Sectors
Financials (FY)
EV
$2M
Nextgen Biomed Stock Performance
Nextgen Biomed has current market cap of $2M, and enterprise value of $2M.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2M | $2M | — | XXX | XXX | XXX | — |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialNextgen Biomed Valuation Multiples
Nextgen Biomed Financial Valuation Multiples
As of March 11, 2026, Nextgen Biomed has market cap of $2M and EV of $2M.
Equity research analysts estimate Nextgen Biomed's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2M | XXX | $2M | XXX | XXX | XXX |
| EV (current) | $2M | XXX | $2M | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Nextgen Biomed Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Nextgen Biomed Public Comps
See public comps and valuation multiples for other Biopharmaceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Biosenic | XXX | XXX | XXX | XXX | XXX | XXX |
| Aptahem | XXX | XXX | XXX | XXX | XXX | XXX |
| HCW Biologics | XXX | XXX | XXX | XXX | XXX | XXX |
| China SXT Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
| Redwood Scientific Technologies | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Nextgen Biomed M&A Activity
Nextgen Biomed acquired XXX companies to date.
Last acquisition by Nextgen Biomed was on XXXXXXXX, XXXXX. Nextgen Biomed acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Nextgen Biomed
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialNextgen Biomed Investment Activity
Nextgen Biomed invested in XXX companies to date.
Nextgen Biomed made its latest investment on XXXXXXXX, XXXXX. Nextgen Biomed invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Nextgen Biomed
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Nextgen Biomed
| When was Nextgen Biomed founded? | Nextgen Biomed was founded in 1990. |
| Where is Nextgen Biomed headquartered? | Nextgen Biomed is headquartered in Israel. |
| Is Nextgen Biomed publicly listed? | Yes, Nextgen Biomed is a public company listed on Tel Aviv Stock Exchange. |
| What is the stock symbol of Nextgen Biomed? | Nextgen Biomed trades under NXGN ticker. |
| When did Nextgen Biomed go public? | Nextgen Biomed went public in 2000. |
| Who are competitors of Nextgen Biomed? | Nextgen Biomed main competitors are Biosenic, Aptahem, HCW Biologics, China SXT Pharmaceuticals. |
| What is the current market cap of Nextgen Biomed? | Nextgen Biomed's current market cap is $2M. |
| Is Nextgen Biomed profitable? | No, Nextgen Biomed is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.